Stock 4171 GENEREACH BIOTECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs GeneReach Biotechnology Corp.

Equities

4171

TW0004171004

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
31.95 TWD +0.47% Intraday chart for GeneReach Biotechnology Corp. +5.10% -19.01%
Mar. 28 GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

ETFs positioned on GeneReach Biotechnology Corp.

Name Weight AuM 1st Jan change Investor Rating
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 34 M€ +2.14% -

Company Profile

GeneReach Biotechnology Corp. is principally engaged in the manufacture and distribution of animal testing equipment and testing agents. The Company mainly operates through Taiwan segment. The Company provides shrimp virus testing agents, on-site detection systems for fish and shrimp, mini centrifugal machines, pet disease testing agents and other testing equipment.
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data
  1. Stock Market
  2. Equities
  3. 4171 Stock
  4. Funds and ETFs GeneReach Biotechnology Corp.